Abstract:Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making. Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making.

Out with the old, in with the new: Pioneer transcription factors as activators and repressors of lineage specification genes

The yin and yang of pioneer transcription factors: Dual roles in repression and activation

Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate

Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1

Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription During Hematopoiesis

Molecular and epistatic interactions between pioneer transcription factors shape nucleosome dynamics and cell differentiation

Pioneer factor Pax7 initiates two-step cell-cycle-dependent chromatin opening

Myeloid Lineage Choice is Not Controlled by the Pu.1-Gata1 Switch

Lineage Specifiers: New Players in the Induction of Pluripotency

Transcriptional establishment of cell-type identity: dynamics and causal mechanisms of T-cell lineage commitment.

Mechanistic basis of lineage restriction

Dynamic Analysis of Gene Expression and Genome-Wide Transcription Factor Binding During Lineage Specification of Multipotent Progenitors.

Transcription factor co-expression mediates lineage priming for embryonic and extra-embryonic differentiation

CTCF Coordinates Cell Fate Specification Via Orchestrating Regulatory Hubs with Pioneer Transcription Factors

Exploring the reciprocity between pioneer factors and development

Transcriptional network governing extraembryonic endoderm cell fate choice

Hematopoietic Cytokines, Transcription Factors and Lineage Commitment

DNA flexibility regulates transcription factor binding to nucleosomes

Interactome Maps of Mouse Gene Regulatory Domains Reveal Basic Principles of Transcriptional Regulation.

Histone modifications regulate pioneer transcription factor cooperativity